Norges Bank Clovis Oncology, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020
SELL
$3.77 - $11.0 $1.18 Million - $3.44 Million
-313,167 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$3.0 - $16.43 $939,501 - $5.15 Million
313,167 New
313,167 $3.27 Million
Q4 2019

Feb 12, 2020
SELL
$3.0 - $16.43 $884,529 - $4.84 Million
-294,843 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$3.93 - $15.35 $1.16 Million - $4.53 Million
294,843 New
294,843 $1.16 Million
Q3 2019

Nov 08, 2019
SELL
$3.93 - $15.35 $1.83 Million - $7.14 Million
-464,975 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$12.81 - $25.67 $5.96 Million - $11.9 Million
464,975 New
464,975 $6.92 Million
Q2 2019

Aug 09, 2019
SELL
$12.81 - $25.67 $5.96 Million - $11.9 Million
-464,975 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$11.63 - $32.67 $5.41 Million - $15.2 Million
464,975 New
464,975 $8.35 Million
Q4 2018

Feb 08, 2019
SELL
$11.63 - $32.67 $5.41 Million - $15.2 Million
-464,975 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$29.37 - $49.48 $13.7 Million - $23 Million
464,975 New
464,975 $13.7 Million
Q3 2018

Nov 09, 2018
SELL
$29.37 - $49.48 $13.7 Million - $23 Million
-464,975 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$42.06 - $62.4 $19.6 Million - $29 Million
464,975 New
464,975 $21.1 Million
Q2 2018

Jul 23, 2018
SELL
$42.06 - $62.4 $19.6 Million - $29 Million
-464,975 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$50.12 - $67.72 $23.3 Million - $31.5 Million
464,975 New
464,975 $24.6 Million
Q1 2018

May 09, 2018
SELL
$50.12 - $67.72 $24.8 Million - $33.6 Million
-495,656 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$57.69 - $84.58 $28.6 Million - $41.9 Million
495,656 New
495,656 $33.7 Million
Q4 2017

Feb 09, 2018
SELL
$57.69 - $84.58 $27 Million - $39.6 Million
-467,979 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$67.17 - $84.81 $31.4 Million - $39.7 Million
467,979 New
467,979 $38.6 Million
Q3 2017

Nov 07, 2017
SELL
$67.17 - $84.81 $34 Million - $42.9 Million
-505,482 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
63,628 Added 14.4%
505,482 $47.3 Million
Q1 2017

May 11, 2018
BUY
N/A
170,309 Added 62.72%
441,854 $28.1 Million
Q3 2016

Nov 13, 2017
BUY
N/A
271,545
271,545 $0

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email